T1	Participants 40 82	schizophrenia and schizoaffective disorder
T2	Participants 201 242	schizophrenic or schizoaffective patients
T3	Participants 328 370	Patients who did not improve after 6 weeks
T4	Participants 591 627	The results obtained in 111 patients
T5	Participants 733 778	Patients in the high haloperidol plasma range
